Genentech GO29527

A Phase III, Open label, Randomized Study to Investigate the Efficacy and Safety of MPDL3280A (Anti-PDL1 Antibody) Compared With Standard of Care Following Adjuvant Cisplatin-based Chemotherapy in PDL-1 Selected Patients with Completely Resected Stage IB-IIIA Non-Small Cell Lung Cancer

Disease Types

Lung Cancer

Available at

BethesdaClintonColumbiaRockvilleSilver SpringWheaton


Cheryl A. Young, RN, BSN
(410) 964-2212 ext 1137